Walking prescription of 10 000 steps per day in patients with type 2 diabetes mellitus: a randomised trial in Nigerian general practice

In clinical practice, translating the benefits of a sustained physically active lifestyle on glycaemic control in patients with type 2 diabetes mellitus (T2DM) is difficult. A walking prescription may be an effective alternative. To examine the effect of a 10 000 steps per day prescription on glycae...

Full description

Saved in:
Bibliographic Details
Published in:British journal of general practice 2018-02, Vol.68 (667), p.e139-e145
Main Authors: Fayehun, Ayorinde F, Olowookere, Olufemi O, Ogunbode, Adetola M, Adetunji, Adedotun A, Esan, Arinola
Format: Article
Language:English
Subjects:
Accelerometry
Adult
Diabetes
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - physiopathology
Diabetes Mellitus, Type 2 - therapy
Evidence-based medicine
Exercise Therapy
Family physicians
Female
General Practice
Glycated Hemoglobin - metabolism
Humans
Intervention
Male
Middle Aged
Nigeria
Patient Compliance - statistics & numerical data
Treatment Outcome
Walking
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In clinical practice, translating the benefits of a sustained physically active lifestyle on glycaemic control in patients with type 2 diabetes mellitus (T2DM) is difficult. A walking prescription may be an effective alternative. To examine the effect of a 10 000 steps per day prescription on glycaemic control of patients with T2DM. Forty-six adults with T2DM attending a general outpatient clinic were randomised into two equal groups. The intervention group was given goals to accumulate 10 000 steps per day for 10 weeks, whereas the control group maintained their normal activity habits. Daily step count was measured with waist-mounted pedometer and baseline and endline average steps per day. Glycosylated haemoglobin (HbA1c), anthropometric, and cardiovascular measurements were also obtained. An intention-to-treat analysis was done. The average baseline step count was 4505 steps per day for all participants, and the average step count in the intervention group for the last 4 weeks of the study period was higher by 2913 steps per day (95% confidence interval [CI] = 1274 to 4551, (2, 37.7) = 18.90,
ISSN:0960-1643
1478-5242
DOI:10.3399/bjgp18X694613